My Qualifications
BPharm (Hon), MD, PhD
My Awards
My Research Activities
Hosie A; Agar MR; Ries N; Hepworth A; Sanders RD; Kramer K; Evered L; Ma D; van Oosterom N; Devlin JW, 2026, 'Understanding the Unique Ethical Challenges in Randomized Controlled Trials of Delirium Interventions for Older Adults: A Rapid Review.', Anesth Analg, http://dx.doi.org/10.1213/ANE.0000000000007930, ROS ID: 2674278
van...view more
My Qualifications
BPharm (Hon), MD, PhD
My Awards
My Research Activities
Hosie A; Agar MR; Ries N; Hepworth A; Sanders RD; Kramer K; Evered L; Ma D; van Oosterom N; Devlin JW, 2026, 'Understanding the Unique Ethical Challenges in Randomized Controlled Trials of Delirium Interventions for Older Adults: A Rapid Review.', Anesth Analg, http://dx.doi.org/10.1213/ANE.0000000000007930, ROS ID: 2674278
van Oosterom N; Barras M; Bird R; Cottrell N, 2025, 'Incidence of aspirin resistance in high-risk patients following elective total hip and knee arthroplasty.', Intern Med J, 55, pp. 2095 - 2098, http://dx.doi.org/10.1111/imj.70204, ROS ID: 2687778
van Oosterom N; Agar MR; Walpole G; Casey P; Moffat P; Bradley K; Cook A; Johnson C; Chye R; Oehme J; Senatore M; Virdun C; Pearson M; Featherstone I; Lawlor PG; Bush SH; Daveson B; Clapham S; Campbell K; Hosie A, 2024, 'Driving quality in delirium care through a patient-centered monitoring system in palliative care: Protocol for the two-staged exploratory sequential mixed methods MODEL-PC study', Delirium, http://dx.doi.org/10.56392/001c.94808, ROS ID: 2208761
van Oosterom N; Barras M; Cottrell N, 2024, 'Prevalence of risk factors for venous thromboembolism and aspirin resistance in Australian patients undergoing total hip and knee arthroplasty.', Intern Med J, 54, pp. 1275 - 1282, http://dx.doi.org/10.1111/imj.16407, ROS ID: 2687780
van Oosterom N; Barras M; Cottrell N, 2024, 'Prevention of venous thromboembolism after total hip and knee arthroplasties in Australian hospitals: what are we using?', Journal of Pharmacy Practice and Research, 54, pp. 287 - 295, http://dx.doi.org/10.1002/jppr.1919, ROS ID: 2687777
van Oosterom N; De Guzman KR; Winckel K; Johnson A; Falconer N, 2023, 'Evaluation of the Quality and Safety of Venous Thromboembolism Prophylaxis Among Gastroenterology Inpatients at a Tertiary Hospital in Australia.', Hosp Pharm, 58, pp. 595 - 604, http://dx.doi.org/10.1177/00185787231172385, ROS ID: 2687783
van Oosterom N; Barras M; Cottrell N, 2023, Prevention of venous thromboembolism after total hip and knee arthroplasties in Australian hospitals: A call for concord, http://dx.doi.org/10.22541/au.167583242.29557904/v1, ROS ID: 2687782
Van Oosterom N; Barras M; Cottrell N; Bird R, 2022, 'Platelet Function Assays for the Diagnosis of Aspirin Resistance.', Platelets, 33, pp. 329 - 338, http://dx.doi.org/10.1080/09537104.2021.1942816, ROS ID: 2687786
van Oosterom N; Barras M; Bird R; Nusem I; Cottrell N, 2020, 'A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery.', Drugs, 80, pp. 1889 - 1899, http://dx.doi.org/10.1007/s40265-020-01413-w, ROS ID: 2687785
van Oosterom N; Winckel K; Barras M, 2020, 'Comment On: "Stratifying Therapeutic Enoxaparin Dose in Morbidly Obese Patients by BMI Class: A Retrospective Cohort Study".', Clin Drug Investig, 40, pp. 287 - 288, http://dx.doi.org/10.1007/s40261-020-00889-4, ROS ID: 2687779
van Oosterom N; Winckel K; Barras M, 2019, 'Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity.', J Thromb Thrombolysis, 48, pp. 387 - 393, http://dx.doi.org/10.1007/s11239-019-01847-4, ROS ID: 2687776
van Oosterom N; Theodoros T, 2019, 'Paliperidone Long-Acting Injections in Huntington's Disease for Motor and Behavioural Disturbances.', Clin Drug Investig, 39, pp. 407 - 410, http://dx.doi.org/10.1007/s40261-019-00759-8, ROS ID: 2687784
Theses / Dissertations
van Oosterom N, Aspirin for the prophylaxis of venous thromboembolic events, http://dx.doi.org/10.14264/1c7336f, ROS ID: 2687781